BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• BioCapital

  Sucampo Pharmaceuticals, Inc. Invites Investors To Listen To Webcast Of Presentation At UBS Conference

  September 24, 2008

   · 

  1 min read
• Drug Development

  PharmAthene, Inc. Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference

  September 24, 2008

   · 

  10 min read
• Eurobiopartnering – The Eurobio 2008 Business Convention: A True Platform For Networking And Dialogue With International Stakeholders In The Biotechnology Industry

  September 24, 2008

   · 

  3 min read
• Business

  Grameen Health to Establish Independent Collaborations with Pfizer Inc., GE Healthcare, and Mayo Clinic to Create Sustainable Healthcare Delivery Models for the Developing World

  September 24, 2008

   · 

  1 min read
• Policy

  BioMimetic Therapeutics, Inc. Announces No Changes Requested by Independent Data Monitoring Committee to Pivotal Trial Design for Augment™ Bone Graft

  September 24, 2008

   · 

  1 min read
• Drug Development

  NPS Pharmaceuticals, Inc. Release: GATTEX(TM) Abstracts to be Presented at ACG Meeting; 52-Week Data from Phase 3 Clinical Trial Scheduled for Plenary Session

  September 24, 2008

   · 

  1 min read
• Drug Development

  Vertex Pharmaceuticals Incorporated Announces Correction to Abstract Data Published in October 2008 Supplement to Hepatology

  September 24, 2008

   · 

  1 min read
• Business

  TransEnterix Names Experienced Medical Device Executive Todd M. Pope as President, CEO

  September 24, 2008

   · 

  1 min read
• BioMidwest

  Zynex Medical Holdings, Inc. Announces a $3 Million Line of Credit

  September 24, 2008

   · 

  1 min read
• Drug Development

  QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy

  September 24, 2008

   · 

  5 min read